Hanmi spends 15% of revenue on R&D

Published: 2010-08-24 06:59:00

Updated: 2010-08-24 06:59:00

Details of drug company spending revealed in the first half of this year show that a combined spending of the country's top pharmaceutical companies (29 companies listed in the Korean Exchange plus 17 companies listed in Kosdaq) was 266.3 billion won, up 16 percent from 2009 while they dished out...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK